The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Abstract
Although the inverse relationship between plasma levels of high-density lipoprotein (HDL) and cardiovascular disease has been largely demonstrated, many observations have suggested that the assessment of HDL functionality might be more informative than a simple measurement of HDL-cholesterol plasma levels. HDLs are a class of structurally and functionally heterogeneous particles; in atherosclerosis-related diseases, changes in HDL subfraction levels and functions are frequently observed. Circulating levels of large HDL particles are decreased in dyslipidaemic conditions, while levels of small dense HDL particles are increased in patients with coronary heart disease. Furthermore, specific genetic defects in proteins involved in HDL metabolism significantly impact the distribution of HDL subpopulations. Finally, many drugs used for dyslipidaemia induce changes in HDL subfractions strictly related to cardiovascular disease. Although several methods exist to evaluate HDL subclass levels, most of them are not easily applicable in clinical practice, due to the costs and high variability. However, the possibility to measure the levels of specific HDL subfractions in patients with atherosclerosis-related diseases might help to better define their cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA · doi:10.1001/2012.jama.11374 · Cited by 960
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Assmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90550-i · Cited by 872
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
von Eckardstein, A., Nofer, J.-R., & Assmann, G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 695
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Zhou, B. (2002) · PubMed · Cited by 558
Otvos, J. D., Collins, D., Freedman, D. S., Shalaurova, I., Schaefer, E. J., McNamara, J. R., Bloomfield, H. E., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.565135 · Cited by 547
Chung, B. H., Wilkinson, T., Geer, J. C., & Segrest, J. P. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39807-2 · Cited by 547
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
Mackness, M. I., Harty, D., Bhatnagar, D., Winocour, P. H., Arrol, S., Ishola, M., & Durrington, P. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90215-o · Cited by 492
Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 477
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
Camont, L., Chapman, M. J., & Kontush, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.013 · Cited by 471
Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins
Mackness, M. I., Mackness, B., Durrington, P. N., Connelly, P. W., & Hegele, R. A. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199604000-00004 · Cited by 447
Sampson, U. K., Fazio, S., & Linton, M. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0219-7 · Cited by 439
HDL, its enzymes and its potential to influence lipid peroxidation
Mackness, M. I., & Durrington, P. N. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05524-m · Cited by 418
Goldbourt, U., Yaari, S., & Medalie, J. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.1.107 · Cited by 391
Biology of regional body fat distribution: Relationship to non‐insulin‐dependent diabetes mellitus
Kissebah, A. H., & Peiris, A. N. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050202 · Cited by 389
Kwak (2012) · doi:10.1001/archinternmed.2012.262 · Cited by 368
Salonen, J. T., Salonen, R., Seppänen, K., Rauramaa, R., & Tuomilehto, J. (1991) · Circulation · doi:10.1161/01.cir.84.1.129 · Cited by 360
Antiatherogenic small, dense HDL—guardian angel of the arterial wall?
Kontush, A., & Chapman, M. J. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0500 · Cited by 342
Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review
Marik, P. E., & Varon, J. (2009) · Clinical Cardiology · doi:10.1002/clc.20604 · Cited by 328
Barbaras, R., Puchois, P., Fruchart, J.-C., & Ailhaud, G. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90451-7 · Cited by 328
Sirtori, C. R., Calabresi, L., Franceschini, G., Baldassarre, D., Amato, M., Johansson, J., Salvetti, M., Monteduro, C., Zulli, R., Muiesan, M. L., et al. (2001) · Circulation · doi:10.1161/01.cir.103.15.1949 · Cited by 322
Kathiresan, S., Otvos, J. D., Sullivan, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W. F., D’Agostino, R. B., Vasan, R. S., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.567107 · Cited by 318
HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study
Després, J.-P., Lemieux, I., Dagenais, G.-R., Cantin, B., & Lamarche, B. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00603-1 · Cited by 316
Tselepis, A. D., & John Chapman, M. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00045-4 · Cited by 314
Kissebah, A. H., Freedman, D. S., & Peiris, A. N. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30695-2 · Cited by 311
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Rye, K.-A., & Barter, P. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000104029.74961.f5 · Cited by 309
The emerging role of HDL in glucose metabolism
Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307
Asztalos, B. F., Cupples, L. A., Demissie, S., Horvath, K. V., Cox, C. E., Batista, M. C., & Schaefer, E. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000146325.93749.a8 · Cited by 298
Matsuura, F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27602 · Cited by 293
Borggreve, S. E., De Vries, R., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 278
Remodelling of high density lipoproteins by plasma factors
Rye, K.-A., Clay, M. A., & Barter, P. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00150-1 · Cited by 273
Asztalos, B. F., Collins, D., Cupples, L. A., Demissie, S., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183727.90611.4f · Cited by 268
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Johansson, J., Carlson, L. A., Landou, C., & Hamsten, A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.174 · Cited by 260
Chapman, M. J., Assmann, G., Fruchart, J.-C., Shepherd, J., & Sirtori, C. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004402 · Cited by 257
Lee, M., Saver, J. L., Towfighi, A., Chow, J., & Ovbiagele, B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.020 · Cited by 240
Nob�court, E., Jacqueminet, S., Hansel, B., Chantepie, S., Grimaldi, A., Chapman, M. J., & Kontush, A. (2005) · Diabetologia · doi:10.1007/s00125-004-1655-5 · Cited by 220
Barrans, A., Collet, X., Barbaras, R., Jaspard, B., Manent, J., Vieu, C., Chap, H., & Perret, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78162-9 · Cited by 217
Characterization of human high density lipoproteins by zonal ultracentrifugation.
Patsch, W., Schonfeld, G., Gotto, A. M., & Patsch, J. R. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85868-4 · Cited by 208
Multiple actions of high-density lipoprotein
Florentin, M., Liberopoulos, E. N., Wierzbicki, A. S., & Mikhailidis, D. P. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283043806 · Cited by 202
Yvan-Charvet, L., Matsuura, F., Wang, N., Bamberger, M. J., Nguyen, T., Rinninger, F., Jiang, X.-C., Shear, C. L., & Tall, A. R. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.106.138347 · Cited by 201
The paradox of dysfunctional high-density lipoprotein
Ansell, B. J., Fonarow, G. C., & Fogelman, A. M. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282364a17 · Cited by 198
Tselepis, A. D., Dentan, C., Karabina, S.-A. P., Chapman, M. J., & Ninio, E. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1764 · Cited by 198
Albers, J. J., Warnick, G. R., Wiebe, D., King, P., Steiner, P., Smith, L., Breckenridge, C., Chow, A., Kuba, K., Weidman, S., et al. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.6.853 · Cited by 197
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender and diet.
Deeb, S. S., Zambon, A., Carr, M. C., Ayyobi, A. F., & Brunzell, J. D. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200017-jlr200 · Cited by 193
Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease
Asztalos, B. F., Roheim, P. S., Milani, R. L., Lefevre, M., McNamara, J. R., Horvath, K. V., & Schaefer, E. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2670 · Cited by 193
Emerging role of high density lipoproteins as a player in the immune system
Norata, G. D., Pirillo, A., Ammirati, E., & Catapano, A. L. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.045 · Cited by 192
Self-citationLuc, G., Bard, J.-M., Ferrières, J., Evans, A., Amouyel, P., Arveiler, D., Fruchart, J.-C., & Ducimetière, P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000022850.59845.e0 · Cited by 180
Lamarche, B., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J.-P. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1098 · Cited by 170
Gazi, I., Lourida, E. S., Filippatos, T., Tsimihodimos, V., Elisaf, M., & Tselepis, A. D. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.058404 · Cited by 162
Dysfunctional HDL as a Diagnostic and Therapeutic Target
Smith, J. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179226 · Cited by 161
Paraoxonase and coronary heart disease
Mackness, M., Mackness, B., & Durrington, P. N. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00046-6 · Cited by 158
Tsimihodimos, V., Karabina, S.-A. P., Tambaki, A. P., Bairaktari, E., Goudevenos, J. A., Chapman, M. J., Elisaf, M., & Tselepis, A. D. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.102918 · Cited by 158
Prevention and Treatment of the Metabolic Syndrome
Daskalopoulou, S. S., Mikhailidis, D. P., & Elisaf, M. (2004) · Angiology · doi:10.1177/00033197040550i601 · Cited by 157
Physiological role and clinical relevance of high-density lipoprotein subclasses
von Eckardstein, A., Huang, Y., & Assmann, G. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199412000-00003 · Cited by 152
Persson, M., Hedblad, B., Nelson, J. J., & Berglund, G. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142679 · Cited by 152
Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol
Bairaktari, E. T., Seferiadis, K. I., & Elisaf, M. (2005) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840501000106 · Cited by 151
Grundy, S. M., & Vega, G. L. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.1.28 · Cited by 145
Change in α 1 HDL Concentration Predicts Progression in Coronary Artery Stenosis
Asztalos, B. F., Batista, M. C., Horvath, K. V., Cox, C. E., Dallal, G. E., Morse, J. S., Brown, G. B., & Schaefer, E. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000066133.32063.bb · Cited by 137
LDL and HDL subclasses in acute ischemic stroke: Prediction of risk and short-term mortality
Zeljković, A., Vekić, J., Spasojević‐Kalimanovska, V., Jelić‐Ivanović, Z., Bogavac‐Stanojević, N., Gulan, B., & Spasić, S. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.040 · Cited by 131
Souza, J. A., Vindis, C., Hansel, B., Nègre‐Salvayre, A., Thérond, P., Junior, C. V. S., Chantepie, S., Salvayre, R., Bruckert, É., Chapman, M. J., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.009 · Cited by 125
Sakai, T., Kamanna, V. S., & Kashyap, M. L. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096624 · Cited by 123
Differential Effect of Hypolipidemic Drugs on Lipoprotein-Associated Phospholipase A 2
Saougos, V. G., Tambaki, A. P., Kalogirou, M., Kostapanos, M. S., Gazi, I. F., Wolfert, R. L., Elisaf, M., & Tselepis, A. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147280 · Cited by 122
Arsenault, B. J., Lemieux, I., Després, J., Gagnon, P., Wareham, N. J., Stroes, E. S. G., Kastelein, J. J. P., Khaw, K., & Boekholdt, S. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.044 · Cited by 121
Drexel, H., Amann, F. W., Rentsch, K., Neuenschwander, C., Luethy, A., Khan, S. I., & Folláth, F. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91186-8 · Cited by 121
Milionis, H. J., Rizos, E. C., Goudevenos, J. A., Seferiadis, K. I., Mikhailidis, D. P., & Elisaf, M. (2005) · Stroke · doi:10.1161/01.str.0000169935.35394.38 · Cited by 120
Modified HDL: Biological and physiopathological consequences
Norata, G. D., Pirillo, A., & Catapano, A. L. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.01.012 · Cited by 109
Self-citationGenetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease
Calabresi, L., Simonelli, S., Gomaraschi, M., & Franceschini, G. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.034 · Cited by 103
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles
Gazi, I. F., Tsimihodimos, V., Tselepis, A. D., Elisaf, M., & Mikhailidis, D. P. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.1.53 · Cited by 98
Williams, P., Krauss, R. M., Nichols, A., VRANIZAN, K. M., & Wood, P. D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42753-1 · Cited by 95
A long and winding road: defining the biological role and clinical importance of paraoxonases
James, R. W. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.207 · Cited by 93
Sethi, A. A., Sampson, M., Warnick, R., Muniz, N., Vaisman, B., Nordestgaard, B. G., Tybjærg-Hansen, A., & Remaley, A. T. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.139931 · Cited by 91
Filippatos, T. D., Gazi, I. F., Liberopoulos, E. N., Athyros, V. G., Elisaf, M., Tselepis, A. D., & Kiortsis, D. N. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.010 · Cited by 86
Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia
Bellanger, N., Orsoni, A., Julia, Z., Fournier, N., Frisdal, É., Duchêne, E., Bruckert, É., Carrié, A., Bonnefont‐Rousselot, D., Pirault, J., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227181 · Cited by 85
Soedamah‐Muthu, S. S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00428-8 · Cited by 83
Do we need to consider inflammatory markers when we treat atherosclerotic disease?
Athyros, V. G., Kakafika, A. I., Karagiannis, A. I., & Mikhailidis, D. P. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.026 · Cited by 81
HDL Cholesterol: Physiology, Pathophysiology, and Management
Link, J. J., Rohatgi, A. K., & de Lemos, J. A. (2007) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2007.01.004 · Cited by 81
Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome
Blatter, M.-C., Kalix, B., Morabia, A., & James, R. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1295 · Cited by 79
Gazi, I. F., Tsimihodimos, V., Filippatos, T. D., Bairaktari, E. T., Tselepis, A. D., & Elisaf, M. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.015 · Cited by 75
Lagos, K. G., Filippatos, T. D., Tsimihodimos, V., Gazi, I. F., Rizos, C. V., Tselepis, A. D., Mikhailidis, D. P., & Elisaf, M. (2008) · Lipids · doi:10.1007/s11745-008-3251-9 · Cited by 74
Relation of Increased Prebeta-1 High-Density Lipoprotein Levels to Risk of Coronary Heart Disease
Guey, L. T., Pullinger, C. R., Ishida, B. Y., O'Connor, P. M., Zellner, C., Francone, O. L., Laramie, J. M., Naya-Vigne, J. M., Siradze, K. A., Deedwania, P., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.054 · Cited by 70
The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease
O’Brien, T., Nguyen, T. T., Hallaway, B. J., Hodge, D. O., Bailey, K. R., Holmes, D. R., & Kottke, B. A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.228 · Cited by 69
Catalano, G., Julia, Z., Frisdal, É., Vedie, B., Fournier, N., Goff, W. L., Chapman, M. J., & Guérin, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179416 · Cited by 69
Michos, E. D., Sibley, C. T., Baer, J., Blaha, M. J., & Blumenthal, R. S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.045 · Cited by 68
Lamon‐Fava, S., Herrington, D. M., Reboussin, D. M., Sherman, M., Horvath, K. V., Cupples, L. A., White, C. C., Demissie, S., Schaefer, E. J., & Asztalos, B. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.157123 · Cited by 67
Bays, H. E., McGovern, M. E., & Kopin, L. (2003) · Preventive Cardiology · doi:10.1111/j.1520-037x.2003.03142.x · Cited by 64
The relationship between high density lipoprotein subclass profile and plasma lipids concentrations
Tian, L., & Fu, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-118 · Cited by 61
Shinkai, H. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s25238 · Cited by 57
Alterations of HDL subclasses in hyperlipidemia
Xu, Y., & Fu, M. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00138-4 · Cited by 54
Ji, J., Watts, G. F., Johnson, A. G., Chan, D. C., Ooi, E. M. M., Rye, K., Serone, A., & Barrett, P. H. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1895 · Cited by 53
Filippatos, T. D., Liberopoulos, E. N., Kostapanos, M., Gazi, I. F., Papavasiliou, E. C., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. S. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00733.x · Cited by 51
Relationship between plasma lipid concentrations and HDL subclasses
Yang, Y., Yan, B., Fu, M., Xu, Y., & Tian, Y. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.11.015 · Cited by 51
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome
Rizos, E. C., Tambaki, A. P., Gazi, I. F., Tselepis, A. D., & Elisaf, M. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.10.021 · Cited by 50
Brites, F. D., Verona, J., Schreier, L. E., Fruchart, J., Castro, G. R., & Wikinski, R. L. W. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.02.002 · Cited by 43
Ottestad, I. O., Halvorsen, B. L., Balstad, T. R., Otterdal, K., Borge, G. I. A., Brosstad, F. R., Myhre, A. M., Ose, L., Nenseter, M. S., & Holven, K. B. (2006) · Journal of Nutrition · doi:10.1093/jn/136.4.877 · Cited by 43
Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease?
Burillo, E., Martín‐Fuentes, P., Mateo‐Gállego, R., Baila-Rueda, L., Cenarro, A., Ros, E., & Civeira, F. (2012) · Current Vascular Pharmacology · doi:10.2174/157016112800812845 · Cited by 43
Albers, J. J., Pitman, W. A., Wolfbauer, G., Cheung, M. C., Kennedy, H., Tu, A.-Y., Marcovina, S. M., & Paigen, B. J. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33369-1 · Cited by 42
Miida, T., Yamaguchi, T., Tsuda, T., & Okada, M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00011-2 · Cited by 42
Asztalos, B. F., Demissie, S., Cupples, L. A., Collins, D. E., Cox, C. E., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.018 · Cited by 42
Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy
Bellanger, N., Julia, Z., Villard, E. F., Khoury, P. E., Duchêne, E., Chapman, M. J., Fournier, N., Goff, W. L., & Guérin, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.027 · Cited by 41
Plasma markers of endothelial dysfunction in type 2 diabetics
Moldoveanu, E., Tanaseanu, C. M., Tănăseanu, Ş., Kosaka, T., Manea, G., Marta, D. S., & Popescu, L. M. (2005) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.09.015 · Cited by 41
Pirillo, A., Uboldi, P., Kuhn, H., & Catapano, A. L. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.009 · Cited by 39
Self-citationDaniil, G., Phedonos, A., Holleboom, A. G., Motazacker, M. M., Argyri, L., Kuivenhoven, J. A., & Chroni, A. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.011 · Cited by 38
Bezafibrate Increases Preβ1-HDL at the Expense of HDL 2b in Hypertriglyceridemia
Miida, T., Sakai, K., Ozaki, K., Nakamura, Y., Yamaguchi, T., Tsuda, T., Kashiwa, T., Murakami, T., Inano, K., & Okada, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2428 · Cited by 37
High-density lipoprotein subfractions as markers of early atherosclerosis
Atger, V., Giral, P., Simon, A. C., Cambillau, M., Levenson, J. A., Gariépy, J., Mégnien, J. L., & MOATTI, N. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)80060-0 · Cited by 35
Mueller, O., Chang, E., Deng, D. X.-F., Franz, T., Jing, D. H., Kincaid, R. H., Konigshofer, Y., Kratzmeier, M., McNulty, M., Qian, H., et al. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.117 · Cited by 34
Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia
Gou, L., Fu, M., Xu, Y., Tian, Y., Yan, B., & Lu-chuan, Y. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.032 · Cited by 33
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus
Kalmár, T., Seres, I., Balogh, Z., Káplár, M., Winkler, G., & Paragh, G. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70233-1 · Cited by 32
Pirillo, A., Uboldi, P., Bolego, C., Kühn, H., & Catapano, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2821 · Cited by 31
Self-citationSaltevo, J. T., Vanhala, M. J., Kautiainen, H., Kumpusalo, E. A., & Laakso, M. (2007) · Mediators of Inflammation · doi:10.1155/2007/93573 · Cited by 31
Arai, T., Tsukada, T., Murase, T., & Matsumoto, K. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00328-4 · Cited by 31
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred
Calabresi, L., Nilsson, P. M., Pinotti, E., Gomaraschi, M., Favari, E., Adorni, M. P., Bernini, F., Sirtori, C. R., Calandra, S., Franceschini, G., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.006 · Cited by 31
Pirillo, A., Uboldi, P., Ferri, N., Corsini, A., Kuhn, H., & Catapano, A. L. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.020 · Cited by 30
Self-citationAlterations of high density lipoprotein subclasses in obese subjects
Tian, L., Jia, L., Fu, M., Tian, Y., Xu, Y., Tian, H., & Yang, Y. (2006) · Lipids · doi:10.1007/s11745-006-5032-7 · Cited by 29
Lee, M., Kim, J. Q., Kim, J.-W., Oh, H., & Park, M.-Y. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00513-5 · Cited by 27
Alterations in lipoprotein defense against oxidative stress in metabolic syndrome
Hansel, B., Kontush, A., Bonnefont‐Rousselot, D., Bruckert, É., & Chapman, M. J. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0026-8 · Cited by 26
Tian, L., Long, S., Li, C., Liu, Y., Chen, Y., Zeng, Z., & Fu, M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-54 · Cited by 25
Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms
Jia, L., Bai, H., Fu, M., Xu, Y., Yang, Y., & Long, S. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.004 · Cited by 23
Low high density lipoprotein−2 concentrations in obese male subjects
Bertiere, M. C., Fumeron, F., Rigaud, D., Malon, D., Apfelbaum, M., & Girard-Globa, A. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90163-3 · Cited by 23
Long, S., Tian, Y., Zhang, R., Yang, L., Xu, Y., Jia, L., & Fu, M. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.010 · Cited by 21
Tian, L., Xu, Y., Fu, M., Peng, T., Liu, Y., & Long, S. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-17 · Cited by 21
Plasma preβ1-HDL level is elevated in unstable angina pectoris
Tashiro, J., Miyazaki, O., Nakamura, Y., Miyazaki, A., Fukamachi, I., Bujo, H., & Saitō, Y. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.10.015 · Cited by 20
Laboratory investigation of dysfunctional HDL
Guo, Z. G., Li, C., Zhong, J. K., Tu, Y., & Xie, D. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.10.005 · Cited by 18
Rysz, J., Błaszczak, R., Banach, M., Kędziora–Kornatowska, K., Kornatowski, T., Tański, W., & Kędziora, J. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0033-7 · Cited by 18
Dallinga‐Thie, G. M., van Tol, A., & Dullaart, R. P. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.008 · Cited by 17
Saïdi, Y., Sich, D., Camproux, A., Egloff, M., Federspiel, M.-C., Gautier, V., Raisonnier, A., Turpin, G., & Beucler, I. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90011-2 · Cited by 16
Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease
Suzuki, M., Wada, H., Maeda, S., Saito, K., Minatoguchi, S., Saito, K., & Seishima, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.041012 · Cited by 15
Tian, L., Long, S., Fu, M., Liu, Y., Xu, Y., & Jia, L. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-64 · Cited by 12
Xian, X., Ma, Y., Yang, D.-H. D., Huang, W. Y., Wang, Y., Mueller, O., Chang, E., Konigshofer, Y., Van-Cleve, M., Yang, J., et al. (2009) · Biomarkers · doi:10.3109/13547500903204636 · Cited by 11
Angiographically-assessed coronary artery disease associates with HDL particle size in women.
Blackburn, P., Lemieux, I., Lamarche, B., Bergeron, J., Perron, P., Tremblay, G., Gaudet, D., & Despres, J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.016 · Cited by 10
Duivenvoorden, R., & Fayad, Z. A. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835916b3 · Cited by 10
Brinton, E. A. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.03.005 · Cited by 9
Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes
Pan, J., Shilian, P., Ishida, B. Y., Wu, X., Kane, J. P., Malloy, M. J., & Charles, M. A. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.029 · Cited by 9
Rosenbaum, D. H., Hansel, B., Bonnefont‐Rousselot, D., Bittar, R., Girerd, X. J., Giral, P., & Bruckert, É. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111431990 · Cited by 8
Research works printed but not linked: 5
- 10.2337/dc06-1948 · doi:10.2337/dc06-1948
- 10.1046/j.1365-2362.1997.1020654.x · doi:10.1046/j.1365-2362.1997.1020654.x
- 10.1016/j.cca.2008.12.012 · doi:10.1016/j.cca.2008.12.012
- 10.1016/j.atherosclerosis.2011.01.051 · doi:10.1016/j.atherosclerosis.2011.01.051
- 10.1515/CCLM.2010.133 · doi:10.1515/cclm.2010.133
Cited by
The Controversial Role of Human Gut Lachnospiraceae
Vacca, M., Celano, G., Calabrese, F. M., Portincasa, P., Gobbetti, M., & De Angelis, M. (2020) · Microorganisms · doi:10.3390/microorganisms8040573 · Cited by 1,688
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Wiegman, A., Gidding, S. S., Watts, G. F., Chapman, M. J., Ginsberg, H. N., Cuchel, M., Ose, L., Averna, M., Boileau, C., Borén, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv157 · Cited by 891
Self-citationDysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Metadata
- Authors
- Pirillo, A., Norata, G. D., & Catapano, A. L.
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 124
- Issue
- 2
- Pages
- 116-125
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W2048070048
- Cited by
- 748
- References
- 152
- FWCI
- 56.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.